A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration

BMC Cancer

Moxuan Zhang¹  Jian Zhang¹  Yanhao Cheng¹  Zhengchun Xue²  Qiang Sun² 

[1]Department of Neurosurgery, Linyi People’s Hospital, 27 Jiefang Road, 276000, Linyi, China

[2]Weifang Medical University, 7166 Baotong Road, 261053, Weifang, China

关键词: Glioma;    Pyroptosis;    Prognostic;    Immune;    Tumor microenvironment;   

DOI  :  10.1186/s12885-021-09046-2

来源: Springer

【 摘 要 】

BackgroundGlioma is the most common primary intracranial tumour and has a very poor prognosis. Pyroptosis, also known as inflammatory necrosis, is a type of programmed cell death that was discovered in recent years. The expression and role of pyroptosis-related genes in gliomas are still unclear.MethodsIn this study, we analysed the RNA-seq and clinical information of glioma patients from The Cancer Genome Atlas (TCGA) database and Chinese Glioma Genome Atlas (CGGA) database. To investigate the prognosis and immune microenvironment of pyroptosis-related genes in gliomas, we constructed a risk model based on the TCGA cohort. The patients in the CGGA cohort were used as the validation cohort.ResultsIn this study, we identified 34 pyroptosis-related differentially expressed genes (DEGs) in glioma. By clustering these DEGs, all glioma cases can be divided into two clusters. Survival analysis showed that the overall survival time of Cluster 1 was significantly higher than that of Cluster 2. Using the TCGA cohort as the training set, a 10-gene risk model was constructed through univariate Cox regression analysis and LASSO Cox regression analysis. According to the risk score, gliomas were divided into high-risk and low-risk groups. Survival analysis showed that the low-risk group had a longer survival time than the high-risk group. The above results were verified in the CGGA validation cohort. To verify that the risk model was independent of other clinical features, the distribution and the Kaplan-Meier survival curves associated with risk scores were performed. Combined with the characteristics of the clinical cases, the risk score was found to be an independent factor predicting the overall survival of patients with glioma. The analysis of single sample Gene Set Enrichment Analysis (ssGSEA) showed that compared with the low-risk group, the high-risk group had immune cell and immune pathway activities that were significantly upregulated.ConclusionWe established 10 pyroptosis-related gene markers that can be used as independent clinical predictors and provide a potential mechanism for the treatment of glioma.

【 授权许可】

CC BY